Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LRCH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KCNN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UQCRHL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
POU6F1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A40 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM200C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MATN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HGD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MKRN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NRF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNPY3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STKLD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LDLR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCBLD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKCE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on